The Ontario, Canada government recently announced that the BresoDx will be available later this year for patients to take home from up to 25 clinics across the province, reports Financial Post.
Shahira Bhimani, the director of MaRS Excite, says the two-year BresoDx demonstration project — in which up to 3,000 Ontarians a year will try out the device — is “a huge win.”
The Excite program is designed to address the peril involved in taking a new device to market without ensuring there’s at least provincial demand for the product, she says. The program aims to “innovate in the direction the health system is going,” Bhimani says.
